LOG IN | REGISTERKanbay Community
  
Contact Kanbay Consulting

Jump Menus

Kanbay Case Studies Services at a Glance White Papers
  

Life Sciences

Kanbay's Life Sciences leaders have an average of over 15 years experience in delivering solutions in the industry for top tier consulting firms. Our exceptional expertise makes Kanbay the place to turn to for assistance.

Kanbay works in and across the healthcare value chain, addressing the needs of our clients from all walks of healthcare:

The healthcare chain is a complex set of interactions between these participants. Kanbay's knowledge of the industry lets us craft solutions for individual clients that take into account the complexity of operations "within the walls" of an organization but also optimize for the overall value chain:

Healthcare industry

Kanbay's clients come from across this value chain and include:

Life Sciences manufacturers face continuous set of challenges across many spectrums as described below.

Return on Innovation

With significant investments in R&D, continuous need to replenish product pipelines, and ever lengthening of high-failure time-to-market approval processes, Life Science manufacturers are seeking ways to increase return on product R&D and speed the delivery process. These efforts include everything from mining past clinical data for new results, streamlining operations across CRO's, clinicians, contract manufacturers, and critical suppliers with electronic linkages and collaborative technologies, to intellectual property management.

Many Pharmaceutical, Biotech, Generic, OTC, Nutraceutical and Medical Device companies are establishing connectivity with research partners, thought leaders. The industry is in an upswing of in-licensing, merger and acquisition activity, as companies seek both greater economies of scale and "economies of skill", making management of intellectual property through the M&A process critical.

Maximizing "Time-in-Market" and Return on Sales and Marketing

Time-to-market on product is only the initial issue facing Pharmaceutical companies today. Patent expirations have caused product revenue reductions of over 90% in the first weeks of patent expiry. The mantra is enhancing "time in market".

Maximizing the effectiveness of all promotional activities, from sales to marketing, as well as the increasingly critical areas of managed care contracting, from traditional payers to emerging growth markets in employer and LTC, to educational and scientific liaison efforts around evidence-based clinical outcomes data are all critical to increasing the capture of a product's full value in the marketplace, and business intelligence and full contract, customer and influencer relationship tools are critical to this process.

Reducing Compliance Risks & Costs

There are mounting regulatory pressures facing pharmaceutical, biotech and device manufacturers. The headlines and associated significant value reduction from drug withdrawals driven by manufacturing issues, out-of-compliance government pricing, lack of global complaint and adverse event management, quality program issues, and drug withdrawals are well documented.

Life Science organizations need to effectively and efficiently address issues around compliance with regulatory agency requirements, while improving their organization's performance as it relates to drug safety and quality along the entire value chain.